kras mutation and glutathion Metabolic networks in mutant KRAS-driven tumours: tissue specificities the microenvironment Uncovering new therapeutic targets for
Uncovering new therapeutic targets for a common KRAS mutation behind cancer Targeting mutated GTPase KRAS in tumor therapies ScienceDirect Kinetic and Redox Characterization of KRAS G12C Inhibition bioRxiv kras mutation and glutathion glynac Glutathione Depletion Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy Isoform Specific Destabilization of the Active Research advances in the treatment of KRAS mutant colorectal cancer from Prof. Guoquan Gao's group at Zhongshan School of Medicine SUN YAT SEN UNIVERSITY
Pay in 4 interest-free payments of $5.65 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24




